Literature DB >> 16907733

Growth inhibition of Candida species and Aspergillus fumigatus by statins.

Ian G Macreadie1, Georgia Johnson, Tanja Schlosser, Peter I Macreadie.   

Abstract

Statins are a class of drugs widely used for lowering high cholesterol levels through their action on 3-hydroxy-3-methylglutaryl-CoA reductase, a key enzyme in the synthesis of cholesterol. We studied the effects of two major statins, simvastatin and atorvastatin, on five Candida species and Aspergillus fumigatus. The statins strongly inhibited the growth of all species, except Candida krusei. Supplementation of Candida albicans and A. fumigatus with ergosterol or cholesterol in aerobic culture led to substantial recovery from the inhibition by statins, suggesting specificity of statins for the mevalonate synthesis pathway. Our findings suggest that the statins could have utility as antifungal agents and that fungal colonization could be affected in those on statin therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16907733     DOI: 10.1111/j.1574-6968.2006.00370.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  32 in total

1.  The diversity of polyketide synthase genes from sugarcane-derived fungi.

Authors:  Juan Diego Rojas; Lara Durães Sette; Welington L de Araujo; Mateus Schreiner Garcez Lopes; Luiziana Ferreira da Silva; Renata L A Furlan; Gabriel Padilla
Journal:  Microb Ecol       Date:  2011-09-22       Impact factor: 4.552

2.  Statin therapy and decreased incidence of positive Candida cultures among patients with type 2 diabetes mellitus undergoing gastrointestinal surgery.

Authors:  Elias K Spanakis; Themistoklis K Kourkoumpetis; Grigorios Livanis; Anton Y Peleg; Eleftherios Mylonakis
Journal:  Mayo Clin Proc       Date:  2010-12       Impact factor: 7.616

3.  Mevalonate governs interdependency of ergosterol and siderophore biosyntheses in the fungal pathogen Aspergillus fumigatus.

Authors:  Sabiha Yasmin; Laura Alcazar-Fuoli; Mario Gründlinger; Thomas Puempel; Timothy Cairns; Michael Blatzer; Jordi F Lopez; Joan O Grimalt; Elaine Bignell; Hubertus Haas
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-21       Impact factor: 11.205

4.  Statin Concentrations Below the Minimum Inhibitory Concentration Attenuate the Virulence of Rhizopus oryzae.

Authors:  Anne-Pauline Bellanger; Alexander M Tatara; Fazal Shirazi; Teclegiorgis Gebremariam; Nathaniel D Albert; Russell E Lewis; Ashraf S Ibrahim; Dimitrios P Kontoyiannis
Journal:  J Infect Dis       Date:  2016-03-16       Impact factor: 5.226

5.  Statins and voriconazole induce programmed cell death in Acanthamoeba castellanii.

Authors:  Carmen M Martín-Navarro; Atteneri López-Arencibia; Ines Sifaoui; María Reyes-Batlle; Basilio Valladares; Enrique Martínez-Carretero; José E Piñero; Sutherland K Maciver; Jacob Lorenzo-Morales
Journal:  Antimicrob Agents Chemother       Date:  2015-03-02       Impact factor: 5.191

6.  Evolution of cross-resistance to medical triazoles in Aspergillus fumigatus through selection pressure of environmental fungicides.

Authors:  Jianhua Zhang; Joost van den Heuvel; Alfons J M Debets; Paul E Verweij; Willem J G Melchers; Bas J Zwaan; Sijmen E Schoustra
Journal:  Proc Biol Sci       Date:  2017-09-27       Impact factor: 5.349

7.  Statins in candidemia: clinical outcomes from a matched cohort study.

Authors:  Graeme N Forrest; Angela M Kopack; Eli N Perencevich
Journal:  BMC Infect Dis       Date:  2010-06-04       Impact factor: 3.090

Review 8.  Copper transport and Alzheimer's disease.

Authors:  Ian G Macreadie
Journal:  Eur Biophys J       Date:  2007-11-15       Impact factor: 1.733

9.  Ketanserin, an antidepressant, exerts its antileishmanial action via inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) enzyme of Leishmania donovani.

Authors:  Sushma Singh; Neeradi Dinesh; Preet Kamal Kaur; Baigadda Shamiulla
Journal:  Parasitol Res       Date:  2014-04-12       Impact factor: 2.289

10.  Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and application of statins as a novel effective therapeutic approach against Acanthamoeba infections.

Authors:  Carmen María Martín-Navarro; Jacob Lorenzo-Morales; Rubén P Machin; Atteneri López-Arencibia; José Manuel García-Castellano; Isabel de Fuentes; Brendan Loftus; Sutherland K Maciver; Basilio Valladares; José E Piñero
Journal:  Antimicrob Agents Chemother       Date:  2012-10-31       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.